Test It Earlier, Result It Faster, Makes Us Stronger: How Rapid Viral Diagnostics Enable Therapeutic Success

Overview

Journal Curr Opin Virol

Publisher Elsevier

Specialty Microbiology

Date 2021 Jun 11

PMID 34116392

Citations 6

Authors

Alexander L Greninger

Affiliations

Soon will be listed here.

Abstract

The COVID-19 pandemic has entailed simultaneous revolutions in virology diagnostics, clinical trials management, and antiviral therapy and vaccinology. Over the past year, SARS-CoV-2 diagnostic testing has moved from highly centralized laboratories to at-home and even over the-counter. This transition has been lionized for its potential public health impact via isolation, but has been less examined for its effect on individual health and therapeutics. Since early initiation of antiviral therapy routinely has been associated with greater treatment efficacy for viral infections, these diagnostic testing innovations offer new opportunities for both clinical testing as well as clinical trials for antiviral therapy. Given a rapidly growing antiviral therapeutic pipeline and the profound impact of individual beneficiary outcomes on sculpting reimbursement policy, the therapeutic benefits associated with rapid viral testing may lead to significant adoption beyond potential public health impacts.

Citing Articles

Prospective, multi-site evaluation of the Cepheid Xpert Xpress CoV-2 test on nasal and nasopharyngeal swabs.

Greninger A, Larcena A, Patel A, Webster B, Ulen C, Green D J Clin Microbiol. 2024; 62(12):e0121924.

PMID: 39503494 PMC: 11633094. DOI: 10.1128/jcm.01219-24.

Conceptualizing the Mechanisms of Social Determinants of Health: A Heuristic Framework to Inform Future Directions for Mitigation.

Thimm-Kaiser M, Benzekri A, Guilamo-Ramos V Milbank Q. 2023; 101(2):486-526.

PMID: 37062954 PMC: 10262397. DOI: 10.1111/1468-0009.12642.

New Virus Diagnostic Approaches to Ensuring the Ongoing Plant Biosecurity of Aotearoa New Zealand.

Delmiglio C, Waite D, T Lilly S, Yan J, Elliott C, Pattemore J Viruses. 2023; 15(2).

PMID: 36851632 PMC: 9964515. DOI: 10.3390/v15020418.

A Survey of Public Health Failures During COVID-19.

Dominquez B, Hernandez A, Fernandez-Pacheco A, Taylor L, Kahar P, Khanna D Cureus. 2023; 14(12):e32437.

PMID: 36644033 PMC: 9833812. DOI: 10.7759/cureus.32437.

Health literacy characteristics of over-the-counter rapid antigen COVID-19 test materials.

Fulmer A, Abboud 2nd G, Wallace L Res Social Adm Pharm. 2022; 18(12):4124-4128.

PMID: 35987673 PMC: 9376145. DOI: 10.1016/j.sapharm.2022.08.003.

References

Ginocchio C, Zhang F, Manji R, Arora S, Bornfreund M, Falk L . Evaluation of multiple test methods for the detection of the novel 2009 influenza A (H1N1) during the New York City outbreak. J Clin Virol. 2009; 45(3):191-5. PMC: 7172175. DOI: 10.1016/j.jcv.2009.06.005. View

Chen P, Nirula A, Heller B, Gottlieb R, Boscia J, Morris J . SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19. N Engl J Med. 2020; 384(3):229-237. PMC: 7646625. DOI: 10.1056/NEJMoa2029849. View

Sood N, Shetgiri R, Rodriguez A, Jimenez D, Treminino S, Daflos A . Evaluation of the Abbott BinaxNOW rapid antigen test for SARS-CoV-2 infection in children: Implications for screening in a school setting. PLoS One. 2021; 16(4):e0249710. PMC: 8021178. DOI: 10.1371/journal.pone.0249710. View

Benkeser D, Juraska M, B Gilbert P . Assessing trends in vaccine efficacy by pathogen genetic distance. J Soc Fr Statistique (2009). 2020; 161(1):164-175. PMC: 7685316. View

Xia S, Chen X . Single-copy sensitive, field-deployable, and simultaneous dual-gene detection of SARS-CoV-2 RNA via modified RT-RPA. Cell Discov. 2020; 6(1):37. PMC: 7253471. DOI: 10.1038/s41421-020-0175-x. View

Hogan C, Garamani N, Lee A, Tung J, Sahoo M, Huang C . Comparison of the Accula SARS-CoV-2 Test with a Laboratory-Developed Assay for Detection of SARS-CoV-2 RNA in Clinical Nasopharyngeal Specimens. J Clin Microbiol. 2020; 58(8). PMC: 7383558. DOI: 10.1128/JCM.01072-20. View

Perchetti G, Huang M, Mills M, Jerome K, Greninger A . Analytical Sensitivity of the Abbott BinaxNOW COVID-19 Ag Card. J Clin Microbiol. 2020; 59(3). PMC: 8106729. DOI: 10.1128/JCM.02880-20. View

Barnabas R, Brown E, Bershteyn A, Stankiewicz Karita H, Johnston C, Thorpe L . Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection : A Randomized Trial. Ann Intern Med. 2020; 174(3):344-352. PMC: 7732017. DOI: 10.7326/M20-6519. View

Lundgren J, Grund B, Barkauskas C, Holland T, Gottlieb R, Sandkovsky U . A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19. N Engl J Med. 2020; 384(10):905-914. PMC: 7781100. DOI: 10.1056/NEJMoa2033130. View

10.

Hayden F, Sugaya N, Hirotsu N, Lee N, de Jong M, Hurt A . Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents. N Engl J Med. 2018; 379(10):913-923. DOI: 10.1056/NEJMoa1716197. View

11.

Lieberman J, Pepper G, Naccache S, Huang M, Jerome K, Greninger A . Comparison of Commercially Available and Laboratory-Developed Assays for Detection of SARS-CoV-2 in Clinical Laboratories. J Clin Microbiol. 2020; 58(8). PMC: 7383518. DOI: 10.1128/JCM.00821-20. View

12.

Horby P, Lim W, Emberson J, Mafham M, Bell J, Linsell L . Dexamethasone in Hospitalized Patients with Covid-19. N Engl J Med. 2020; 384(8):693-704. PMC: 7383595. DOI: 10.1056/NEJMoa2021436. View

13.

Bhoyar R, Jain A, Sehgal P, Divakar M, Sharma D, Imran M . High throughput detection and genetic epidemiology of SARS-CoV-2 using COVIDSeq next-generation sequencing. PLoS One. 2021; 16(2):e0247115. PMC: 7888613. DOI: 10.1371/journal.pone.0247115. View

14.

Tworek J, Khan F, Sekedat M, Scheidel C, Malani A . The Utility of Rapid Nucleic Acid Amplification Testing to Triage Symptomatic Patients and to Screen Asymptomatic Preprocedure Patients for SARS-CoV-2. Open Forum Infect Dis. 2021; 8(1):ofaa607. PMC: 7798501. DOI: 10.1093/ofid/ofaa607. View

15.

Shah M, Salvatore P, Ford L, Kamitani E, Whaley M, Mitchell K . Performance of Repeat BinaxNOW Severe Acute Respiratory Syndrome Coronavirus 2 Antigen Testing in a Community Setting, Wisconsin, November 2020-December 2020. Clin Infect Dis. 2021; 73(Suppl 1):S54-S57. PMC: 8135465. DOI: 10.1093/cid/ciab309. View

16.

Dao Thi V, Herbst K, Boerner K, Meurer M, Kremer L, Kirrmaier D . A colorimetric RT-LAMP assay and LAMP-sequencing for detecting SARS-CoV-2 RNA in clinical samples. Sci Transl Med. 2020; 12(556). PMC: 7574920. DOI: 10.1126/scitranslmed.abc7075. View

17.

Yoon S, Yang S, Cho H, Eun S, Koo C, Kim M . Point-of-care testing for the detection of SARS-CoV-2: a systematic review and meta-analysis. Eur Rev Med Pharmacol Sci. 2021; 25(1):503-517. DOI: 10.26355/eurrev_202101_24422. View

18.

Pollock N, Jacobs J, Tran K, Cranston A, Smith S, OKane C . Performance and Implementation Evaluation of the Abbott BinaxNOW Rapid Antigen Test in a High-Throughput Drive-Through Community Testing Site in Massachusetts. J Clin Microbiol. 2021; 59(5). PMC: 8091851. DOI: 10.1128/JCM.00083-21. View

19.

Chandler C, Bourassa L, Mathias P, Greninger A . Estimating the False-Positive Rate of Highly Automated SARS-CoV-2 Nucleic Acid Amplification Testing. J Clin Microbiol. 2021; 59(8):e0108021. PMC: 8288255. DOI: 10.1128/JCM.01080-21. View

20.

Salazar E, Christensen P, Graviss E, Nguyen D, Castillo B, Chen J . Significantly Decreased Mortality in a Large Cohort of Coronavirus Disease 2019 (COVID-19) Patients Transfused Early with Convalescent Plasma Containing High-Titer Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Protein IgG. Am J Pathol. 2020; 191(1):90-107. PMC: 7609241. DOI: 10.1016/j.ajpath.2020.10.008. View